Glass House Brands Inc (GLAS) reports record biomass production and improved costs, but faces gross margin headwinds from trim mix and operational ramp-up.

New analyst coverage puts BSET, GLAS, AROW, NRIM and JBSS in focus as investors seek stock-specific fundamentals amid macro uncertainty.

United-Guardian's rally reflects stronger sales, distribution expansion and recovering cosmetic demand, but valuation and trade risks may limit its near-term appeal.

Glass House Brands recently began trading on the New York Stock Exchange under the ticker “GLAS” after reorganizing around its medical cannabis operations and moving its adult-use activities into a wholly owned subsidiary. This shift, coming on the heels of federal rescheduling of medical cannabis to Schedule III, positions the company to pursue opportunities such as interstate commerce and potential exports to Europe. With these changes as a backdrop, we’ll explore how Glass House Brands’...